Esketamine: Clinical Trials

20 trials of Esketamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 20 Phase 2, 5 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 220Completed 14, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 35Completed 4, Unknown 1
Phase 12Active not recruiting 1, Completed 1

Follow Esketamine: new trials by email Literature Review of Esketamine trials Research Report on Esketamine

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Esketamine, Midazolam (Intravenous) - Suicidal Ideation, Suicidal Behavior
Phase 2Not yet recruitingUniversity of Sao Paulo1062027-04-302026-10-22
Ayahuasca, Esketamine and PTSD
Ayahuasca, Esketamine - Posttraumatic Stress Disorder (PTSD)
Phase 2RecruitingUniversity of Sao Paulo102025-12-202026-01-05
Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)
Esketamine (Intranasal Spray), Massed Prolonged Exposure (PE) - Post Traumatic Stress Disorder PTSD
Phase 1 / Phase 2CompletedThe University of Texas Health Science Center at San Antonio42025-06-092026-01-28
Effects of Esketamine Versus Magnesium Sulfate on Emotional State and Postoperative Pain in Patients Undergoing Nasal Endoscopic Surgery
Esketamine, Magnesium sulfate, Saline - Chronic Rhinosinusitis, Enhanced Recovery After Surgery
Phase 1 / Phase 2Active not recruitingThe Second People's Hospital of Huai'an1442025-03-012025-04-10
Esketamine Combined With Pregabalin on CPSP in Spinal Patients.
S-ketamine and pregabalin, Normal saline and placebo capsule - Esketamine, Pregabaline
Phase 2 / Phase 3UnknownBeijing Tiantan Hospital1502023-11-102023-11-07
Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study
Almond Therapy, Intranasal ketamine (Esketamine), Treatment as Usual - Treatment Resistant Major Depressive Disorder
Phase 2WithdrawnZylorion Health2023-01-152022-11-15
Esketamine Combined With Dexmedetomidine Sedation in Head MRI Examination of Children With Autism Spectrum Disorder
low dos dexmedetomidine, high dos dexmedetomidine, dexmedetomidine and esketamine - Autism Spectrum Disorder, Dexmedetomidine
Phase 2CompletedMaternal and Child Health Hospital of Hubei Province3002022-12-012024-10-09
Ayahuasca and Esketamine for Major Depression
Ayahuasca, Esketamine - Major Depression Severe
Phase 2CompletedUniversity of Sao Paulo222022-10-302025-12-29
Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression
Psychotherapy, Treatment as Usual, Intranasal Ketamine (esketamine) - Treatment Resistant Major Depressive Disorder
Phase 2TerminatedZylorion Health62022-10-132023-03-24
Remimazolam Versus Propofol for Painless Abortion
Remimazolam, Propofol, Esketamine - Anesthesia, Abortion Early
Phase 2CompletedMaternal and Child Health Hospital of Hubei Province1002022-08-012022-12-02
The Effect of Esketamine Combined With Pregabalin on Chronic Postsurgical Pain in Patients After Craniotomy.
S-ketamine and pregabalin, Normal saline and placebo capsule - Chronic Postsurgical Pain
Phase 2 / Phase 3CompletedBeijing Tiantan Hospital2462021-12-202024-08-01
Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.
S-ketamine and pregabalin, Normal saline and placebo capsule - Esketamine, Pregabalin
Phase 2 / Phase 3CompletedBeijing Tiantan Hospital902021-12-012023-07-06
Propofol Versus Ketamine for Rapid Sequence Intubation in Critically Ill Patients
Esketamine, Propofol - Acute Respiratory Failure
Phase 2CompletedFederal University of São Paulo2072021-10-232026-04-17
Esketamine and Perioperative Depressive Symptoms
Esketamine, Normal saline - Depressive Symptoms, Esketamine
Phase 2 / Phase 3CompletedBeijing Tiantan Hospital4352021-02-192025-08-01
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide
Intranasal Placebo, Midazolam Placebo Solution, Midazolam - Depressive Disorder, Major
Phase 2CompletedJanssen Research & Development, LLC1472017-10-052025-04-29
A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide
Esketamine, Placebo - Major Depressive Disorder
Phase 2CompletedJanssen Research & Development, LLC682014-05-232025-04-29
Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy
Esketamine, Saline, Remifentanil - Ketamine, Anesthesia
Phase 2CompletedKK Women's and Children's Hospital902014-03-012026-08-14
A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression
Esketamine 14 mg, Esketamine 28 mg, Esketamine 56 mg - Treatment Resistant Depressive Disorder
Phase 2CompletedJanssen Research & Development, LLC1082014-01-272025-04-29
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
Esketamine, Placebo - Major Depressive Disorder
Phase 2CompletedJanssen Research & Development, LLC302012-06-272025-04-29
The Analgesic Effect of Combined Treatment With Intranasal S-ketamine and Intranasal Midazolam
s-ketamine & midazolam, Morphine PCA - Analgesia, Patient-controlled, Spinal Stenosis
Phase 2 / Phase 3CompletedUniversity Hospital, Basel, Switzerland222011-01-012013-01-29

Conditions studied

Depressive Disorder, Major (3)  ·  Pain, Postoperative (3)  ·  Depression (2)  ·  Depressive Disorder, Treatment-Resistant (2)  ·  Agnosia (1)  ·  Autism Spectrum Disorder (1)  ·  Combat Disorders (1)  ·  Spinal Cord Neoplasms (1)  ·  Spinal Stenosis (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Suicidal Ideation (1)  ·  Suicide Prevention (1)

Sponsors

Beijing Tiantan Hospital (4)  ·  Janssen Research & Development, LLC (4)  ·  University of Sao Paulo (3)  ·  Maternal and Child Health Hospital of Hubei Province (2)  ·  Zylorion Health (2)  ·  Federal University of São Paulo (1)  ·  KK Women's and Children's Hospital (1)  ·  The Second People's Hospital of Huai'an (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  University Hospital, Basel, Switzerland (1)

Countries

China (7)  ·  Brazil (5)  ·  United States (4)  ·  Belgium (3)  ·  Poland (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Singapore (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Ruquan Han, M.D., Ph D. (3)  ·  Pierre Chue, MBBCh (2)  ·  Casey Straud, PsyD (1)  ·  Farida Ithnin, MBBCh (1)  ·  Flavia R Machado, MD, PhD (1)  ·  Linli Yue, MD (1)  ·  Na Li, MD (1)  ·  Raysa Schmidt, MD (1)  ·  Ruquan Han, M.D., Ph D (1)  ·  Wilhelm Ruppen, MD (1)

Results publications

PMID 33128208, PMID 26707087, PMID 28086004, PMID 29202655, PMID 29282469, PMID 29656663, PMID 31270774, PMID 35110300, PMID 35473735, PMID 36776623, PMID 36841794, PMID 38501980, PMID 39915491, PMID 40058488, PMID 41259542, PMID 41870554, PMID 42119799

NIH funding

2016 (1)